5 Key Takeaways

• 1

  Researchers developed LLS-TDI-DNA-PAINT, a super-resolution microscopy method to visualize antibody interactions with cancerous B cells.

• 2

  The study focuses on antibodies targeting the CD20 protein on B cells, relevant in blood cancers like chronic lymphocytic leukemia.

• 3

  Experiments showed that therapeutic antibodies cluster CD20 molecules on Raji B cells, stabilizing microvilli and altering cell shape.

• 4

  The findings challenge the existing classification of therapeutic antibodies into Type I and Type II based on their mechanisms.

• 5

  The LLS-TDI-DNA-PAINT method provides insights into antibody action in both fixed and living states, aiding future immunotherapy development.